首页> 美国卫生研究院文献>other >Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

【2h】

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

机译：Everolimus与Sunitinib在转移性非透明细胞肾细胞癌（ESPN）中的前瞻性评估：一项随机的多中心2期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSunitinib and everolimus are standard first-line and second-line therapies, respectively, in clear cell renal cell carcinoma (ccRCC).

机译：背景：舒尼替尼和依维莫司分别是透明细胞肾细胞癌（ccRCC）的标准一线和二线治疗方法。

著录项

期刊名称 other
作者
Nizar M. Tannir; Eric Jonasch; Laurence Albiges; Emre Altinmakas; Chaan S. Ng; Surena F. Matin; Xuemei Wang; Wei Qiao; Zita Dubauskas Lim; Pheroze Tamboli; Priya Rao; Kanishka Sircar; Jose A. Karam; David F. McDermott; Christopher G. Wood; Toni K. Choueiri;
展开▼
作者单位

展开▼
年(卷),期 -1(69),5
年度 -1
页码 866–874
总页数 18
原文格式 PDF
正文语种
中图分类
关键词
Renal cell carcinoma Non–clear cell renal cell carcinoma Sunitinib Everolimus;

机译：肾细胞癌;非透明细胞肾细胞癌;舒尼替尼;依维莫司;

相似文献

外文文献
中文文献
专利

1. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial [J] . Tannir Nizar M., Jonasch Eric, Albiges Laurence, European urology . 2016,第5期

机译：依维莫司与舒尼替尼对转移性非透明细胞肾细胞癌（ESPN）的前瞻性评估：一项随机的多中心2期试验
2. Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma [J] . MotzerR.J., BarriosC.H., KimT.M., Journal of Clinical Oncology . 2014,第25期

机译：II期随机试验比较了转移性肾细胞癌患者一线依维莫司和二线舒尼替尼与一线舒尼替尼和二线依维莫司的比较
3. Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma [J] . MotzerR.J., BarriosC.H., KimT.M., Journal of Clinical Oncology . 2014,第25期

机译：II期随机试验比较了转移性肾细胞癌患者一线依维莫司和二线舒尼替尼与一线舒尼替尼和二线依维莫司的比较
4. Designing Phase III Trials in Metastatic Renal Cell Carcinoma: What Are the New Standards? [C] . Ana M. Molina Genitourinary Cancers Symposium . 2012

机译：在转移性肾细胞癌中设计III期试验：新标准是什么？
5. Cerebrospinal fluid diversion and intrathecal pressure monitoring in the setting of acute spinal cord injury: A multicenter prospective randomized control trial. [D] . Anthony, Michael P. 2013

机译：急性脊髓损伤情况下的脑脊液转移和鞘内压监测：一项多中心前瞻性随机对照试验。
6. Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma [O] . Robert J. Motzer, Carlos H. Barrios, Tae Min Kim, -1

机译：转移性肾细胞癌患者序贯一线依维莫司和二线舒尼替尼与一线舒尼替尼和二线依维莫司的二期随机对照比较
7. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial [O] . Nizar M. Tannir, Eric Jonasch, Laurence Albiges, 2016

机译：埃弗洛米斯与孙尼替尼的转移性非透明细胞肾细胞癌（ESPN）进行评价：随机多中心2阶段试验

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

摘要

著录项

相似文献

相关主题

期刊订阅